Consultancy
Our consultancy will enable the acceleration, growth, and innovation of drug development through partnership, collaboration, and expert guidance.
Proteomics-informed in vitro to in vivo extrapolation (IVIVE) of drug metabolism and drug transport and physiologically-based pharmacokinetic (PBPK) modeling.
Proteomics method development for quantification of drug metabolizing enzymes (DMEs) and transporters.